$HTFL

Verghese Vikram sold $1.2M of HTFL

Verghese Vikram (Chief Financial Officer) sold 24,345 shares of Heartflow, Inc. (HTFL) at an average of $50.55 ($50.11–$50.75, $1.23M total) across 2 trades over 2026-09-17 to 2026-09-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Verghese Vikram
Published Sep 19, 2026, 12:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 19, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HTFL
Bearish
medium confidence
Mentioned
$HTFL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as a bearish signal by the market.

02

Market read

While the transaction is modest, CFO insider activity can affect short‑term price dynamics.

03

What to watch

Potential tax planning or diversification motives for the CFO.

Relevance 5/10Novelty 4/10Timing: filed Sep 18, 2026

Background

Form 4 filings disclose insider transactions; CFO sales are monitored for sentiment cues.

Company-level read

Ticker impact

$HTFLBearishMedium confidence
Context

CFO Verghese Vikram sold 24,345 shares for $1.23M via a 10b5‑1 plan, reducing his stake to 155,183 shares.

Expected impact

Possible modest downside pressure in the next few trading sessions.

Evidence & confidence

The sale size is modest relative to market cap, but CFO insider activity often influences sentiment.

Market effects

Minimal impact on the broader cardiovascular diagnostics sector.

Limited to U.S. investors tracking Heartflow.

Low global relevance.

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • Verghese Vikram

    Chief Financial Officer of Heartflow, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HTFLHigh

HTFL Soars After Q2 Beat And Raised 2026 Revenue Outlook

HeartFlow (HTFL) stock rose 9.63% after Q2 earnings beat and raised 2026 revenue outlook. Q2 revenue was $64.08M with 80.1% gross margin, but -55.8% profit margin. Company has strong liquidity with $162.55M cash and low debt. Analysts see near-term support at $46-$47 and resistance at $54-$56, with a 12-month target of $60 if growth continues.

$HTFLMedAI 8/10

Why Heartflow Stock Soared Today

HeartFlow (HTFL) shares rose after the company raised its full-year revenue targets. Revenue grew 48% YoY to $64.1M in Q2, with adjusted gross margin increasing to 83.3%. The company now expects 40-42% revenue growth for 2026, up from prior forecasts. CEO John Farquhar cited improved operating leverage and scalability.